Pulsenmore (PLSM) Surges As Ouma Health Deal Ignites US Momentum

Pulsenmore Ltd. stocks have been trading up by 36.72 percent amid heightened optimism from its most recent strategic healthcare partnership.

Live Update At 09:18:15 EDT: On Monday, July 13, 2026 Pulsenmore Ltd. stock [NASDAQ: PLSM] is trending up by 36.72%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

Pulsenmore Ltd. has turned into a fast-moving story stock, and the recent numbers back that up. Before the Ouma Health headline, PLSM traded in the mid-$3s, closing at $3.41 on 2026/06/23 and $3.45 on 2026/06/22 and 2026/06/18. Then the partnership news hit on 2026/06/24, and PLSM exploded from a $3 handle to an intraday high near $13 before closing at $6.59. That is classic low-float, catalyst-driven action.

In the days that followed, Pulsenmore cooled but stayed elevated, grinding between roughly $4.5 and $6.5. The daily chart shows a big gap-up spike, then a staircase of lower highs — a normal pattern as early buyers lock in gains and new traders test dip-buy zones.

Fundamentally, Pulsenmore carries an enterprise value around $18.07M and trades at about 2.99 times sales and 4.6 times book value. Book value per share sits near $4.01, not far from recent prices, which gives traders a rough “floor” to watch. The balance sheet shows total assets of $31.93M against $5.88M in liabilities and minimal long-term debt, suggesting Pulsenmore is not heavily leveraged. Return on capital is still negative, so PLSM remains a growth story that depends on execution, not current profits.

Why Traders Are Watching Pulsenmore Now

PLSM is back on radar screens because the Ouma Health deal flipped a sleepy med-tech name into a momentum playground. On 2026/06/24, Pulsenmore announced a partnership with Ouma Health to expand its remote prenatal care offerings in the US. The market did not shrug. PLSM shares spiked hard, and trading volume went through the roof compared with normal levels.

For active traders, that surge in Pulsenmore volume matters more than any slide deck. Volume is proof that capital cares. When PLSM ripped from the low-$3s to nearly $13 intraday, it signaled that traders are willing to chase the US remote prenatal care story, at least in the short term. The 5‑minute chart shows wild swings — a gap from the $4s to above $6, then a vertical push into the $10s and $12s, followed by sharp pullbacks. That kind of action creates both opportunity and danger.

The key narrative is simple enough for any trader to understand. Pulsenmore wants to bring at‑home ultrasound and remote monitoring into more US pregnancies, and Ouma Health becomes its on-the-ground partner. That expansion pitch resonated with the market, turning PLSM into a momentum name rather than a forgotten micro-cap. As long as Pulsenmore holds above prior support zones and volume stays elevated, short-term traders will keep scanning this chart for breakouts, dip buys, and potential dead‑cat bounces.

Conclusion

Pulsenmore Ltd. is a textbook example of how one well-timed catalyst can change the trading profile of a stock overnight. PLSM went from tight daily ranges near $3–$4 to a multi-bagger intraday spike on the Ouma Health partnership news, with volume swelling far beyond its usual baseline. That reaction tells traders the market is paying attention to Pulsenmore’s US remote prenatal care push.

From a numbers view, PLSM still trades like an early‑stage growth play. The company has a relatively clean balance sheet, modest enterprise value, and negative return on capital. That means the Pulsenmore story is about future potential, not current earnings power. When price rides ahead of fundamentals like this, disciplined trading becomes everything. As millionaire penny stock trader and teacher Tim Sykes, says, “Preparation plus patience leads to big profits.” — a reminder that chasing spikes without a plan rarely works as well as waiting for the right setup and executing with discipline.

For active traders studying Pulsenmore now, the game plan is to respect both the volatility and the catalyst. The big spike around the Ouma Health deal set clear reference points: gap levels, intraday highs, and consolidation zones that PLSM will battle around in coming weeks. As Tim Sykes likes to say, “Patterns repeat, but only if you’re prepared.” Pulsenmore has shown what it can do on news. The next test is whether traders treat PLSM as a one-and-done spike, or a recurring opportunity every time the company steps back into the headline flow.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

• Penny Stocks Trading Guide
• Best Penny Stocks Under $1 to Buy Today
• Top 8 Penny Stocks to Watch on Robinhood

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

• AI Penny Stocks
• Robinhood Penny Stocks
• Top Biotech Stocks